StonvexLoading…
StonvexStonvexStonvexCore line items from VNDA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $216.10M | $198.77M | $192.64M | $254.38M |
Operating Income | $-151.17M | $-40.66M | $-13.95M | $6.33M |
Net Income | $-220.47M | $-18.90M | $2.51M | $6.28M |
EPS (Diluted) | $-3.74 | $-0.33 | $0.04 | $0.11 |
Total Assets | $488.95M | $656.20M | $648.44M | $634.25M |
Total Liabilities | $161.76M | $117.66M | $103.53M | $107.05M |
Cash & Equivalents | $84.85M | $102.32M | $135.82M | $135.03M |
Free Cash Flow OCF − CapEx | $-110.44M | $-16.25M | $12.42M | $31.30M |
Shares Outstanding | 59.10M | 58.31M | 57.53M | 56.78M |